An inside take a look at a Middle for Most cancers Analysis trial with Dr. Christian Hinrichs and his affected person, Sue Scott.
Dr. Hinrichs conducts primary and medical analysis to find and develop novel T-cell therapies for the remedy of sufferers with most cancers. This work features a medical trial of HPV-targeted tumor-infiltrating T cells for sufferers with HPV+ cancers, which has demonstrated that this remedy can mediate full regression of cervical most cancers in some sufferers. Dr. Hinrichs’ laboratory additionally has found genes for T-cell receptors that concentrate on HPV, and his group is testing new gene remedy therapies primarily based on these receptors for sufferers with superior HPV+ tumors.
The Middle for Most cancers Analysis (CCR) is part of the Nationwide Most cancers Institute.
For extra on CCR:
To seek for medical trials: